PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Product: Lisdexamfetamine
Presentation Product Chemical substance Chapter Items dispensed
Lisdexamfetamine 50mg capsules
0404000U0AAADAD
Lisdexamfetamine Lisdexamfetamine dimesylate Central Nervous System 23,446
Lisdexamfetamine 30mg capsules
0404000U0AAABAB
Lisdexamfetamine Lisdexamfetamine dimesylate Central Nervous System 18,473
Lisdexamfetamine 70mg capsules
0404000U0AAAFAF
Lisdexamfetamine Lisdexamfetamine dimesylate Central Nervous System 14,966
Lisdexamfetamine 40mg capsules
0404000U0AAACAC
Lisdexamfetamine Lisdexamfetamine dimesylate Central Nervous System 13,371
Lisdexamfetamine 20mg capsules
0404000U0AAAAAA
Lisdexamfetamine Lisdexamfetamine dimesylate Central Nervous System 9,892
Lisdexamfetamine 60mg capsules
0404000U0AAAEAE
Lisdexamfetamine Lisdexamfetamine dimesylate Central Nervous System 8,343

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.